SCHEMBL3741710

SCHEMBL3741710

CCC(O)(C(=O)O)c1ccc(C)nc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 1/20 0.39
KMT2A Q03164 4/20 0.32
MEN1 O00255 3/20 0.32
LMNA P02545 2/20 0.32
ABCC4 O15439 1/20 0.32
PKM P14618 1/20 0.32
PTGS1 P23219 1/20 0.32
ALOX15 P16050 1/20 0.31
KDM4E B2RXH2 2/20 0.31
GAA P10253 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
RORC P51449 3/20 0.31
P2RX7 Q99572 1/20 0.30
MAPT P10636 1/20 0.30
ALDH1A1 P00352 2/20 0.30
HTT P42858 1/20 0.30
NPC1 O15118 1/20 0.30
HPGD P15428 1/20 0.30
AKR1C3 P42330 1/20 0.30
AKR1C2 P52895 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3747781 0.75 P2RX7 (0.41) KMT2AKDM4ETDP1P2RX7MAPT
SCHEMBL26076103 0.71 SSTR4 (0.38) SSTR4KDM4EALDH1A1
SCHEMBL3504696 0.70 HPGD (0.38) KMT2ALMNAKDM4EGAATDP1
SCHEMBL3737360 0.70 SSTR4 (0.35) SSTR4KMT2AMEN1KDM4EALDH1A1
SCHEMBL3836133 0.70 KDM4E (0.33) KDM4EALDH1A1HPGD
SCHEMBL3740311 0.70 TSHR (0.38) KMT2AMEN1KDM4EGAAMAPT
SCHEMBL11826461 0.69 KCNN4 (0.45) KMT2AMEN1ALOX15KDM4EGAA
SCHEMBL1927339 0.69 OPRK1 (0.43) KMT2ALMNAALDH1A1HTTNPC1
SCHEMBL11836435 0.67 ATM (0.40) KMT2AMEN1LMNAPKMGAA
SCHEMBL7463280 0.67 FFAR1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GIPR, GHSR, GLP1R SSTR4 23/4885KMT2A 3646/4885MEN1 3070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.